Vident Investment Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-11,719
| Closed | -$633K | – | 156 |
|
|
2023
Q2 | $633K | Sell |
11,719
-3,897
| -25% | -$210K | 0.02% | 605 |
|
|
2023
Q1 | $781K | Buy |
15,616
+1,043
| +7% | +$52.2K | 0.03% | 607 |
|
|
2022
Q4 | $674K | Buy |
14,573
+1,689
| +13% | +$78.2K | 0.03% | 608 |
|
|
2022
Q3 | $390K | Buy |
12,884
+1,441
| +13% | +$43.6K | 0.01% | 837 |
|
|
2022
Q2 | $425K | Sell |
11,443
-6,640
| -37% | -$247K | 0.01% | 910 |
|
|
2022
Q1 | $799K | Sell |
18,083
-1,233
| -6% | -$54.5K | 0.02% | 781 |
|
|
2021
Q4 | $821K | Sell |
19,316
-16,132
| -46% | -$686K | 0.02% | 778 |
|
|
2021
Q3 | $1.54M | Buy |
35,448
+22,658
| +177% | +$983K | 0.05% | 543 |
|
|
2021
Q2 | $547K | Sell |
12,790
-12,180
| -49% | -$521K | 0.02% | 812 |
|
|
2021
Q1 | $965K | Buy |
24,970
+5,711
| +30% | +$221K | 0.03% | 621 |
|
|
2020
Q4 | $692K | Buy |
19,259
+686
| +4% | +$24.6K | 0.03% | 633 |
|
|
2020
Q3 | $710K | Buy |
18,573
+7,733
| +71% | +$296K | 0.04% | 586 |
|
|
2020
Q2 | $381K | Buy |
+10,840
| New | +$381K | 0.02% | 716 |
|
|
2018
Q1 | – | Sell |
-20,007
| Closed | -$496K | – | 900 |
|
|
2017
Q4 | $496K | Buy |
+20,007
| New | +$496K | 0.02% | 578 |
|
|
2016
Q4 | – | Sell |
-20,070
| Closed | -$478K | – | 381 |
|
|
2016
Q3 | $478K | Buy |
+20,070
| New | +$478K | 0.06% | 363 |
|
|
2015
Q4 | – | Sell |
-218
| Closed | -$4K | – | 435 |
|
|
2015
Q3 | $4K | Sell |
218
-1,568
| -88% | -$28.8K | ﹤0.01% | 885 |
|
|
2015
Q2 | $32K | Buy |
+1,786
| New | +$32K | ﹤0.01% | 826 |
|